GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Decipher Labs Ltd (BOM:524752) » Definitions » Return-on-Tangible-Equity

Decipher Labs (BOM:524752) Return-on-Tangible-Equity : 19.09% (As of Jun. 2024)


View and export this data going back to 1995. Start your Free Trial

What is Decipher Labs Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Decipher Labs's annualized net income for the quarter that ended in Jun. 2024 was ₹37.9 Mil. Decipher Labs's average shareholder tangible equity for the quarter that ended in Jun. 2024 was ₹198.3 Mil. Therefore, Decipher Labs's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2024 was 19.09%.

The historical rank and industry rank for Decipher Labs's Return-on-Tangible-Equity or its related term are showing as below:

BOM:524752' s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: -70.28   Med: 0.38   Max: 69.74
Current: 1.11

During the past 13 years, Decipher Labs's highest Return-on-Tangible-Equity was 69.74%. The lowest was -70.28%. And the median was 0.38%.

BOM:524752's Return-on-Tangible-Equity is ranked worse than
63.59% of 920 companies
in the Drug Manufacturers industry
Industry Median: 6.195 vs BOM:524752: 1.11

Decipher Labs Return-on-Tangible-Equity Historical Data

The historical data trend for Decipher Labs's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Decipher Labs Return-on-Tangible-Equity Chart

Decipher Labs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.39 13.74 69.74 -12.61 -8.23

Decipher Labs Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.18 -42.23 0.23 24.30 19.09

Competitive Comparison of Decipher Labs's Return-on-Tangible-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Decipher Labs's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Decipher Labs's Return-on-Tangible-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Decipher Labs's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Decipher Labs's Return-on-Tangible-Equity falls into.



Decipher Labs Return-on-Tangible-Equity Calculation

Decipher Labs's annualized Return-on-Tangible-Equity for the fiscal year that ended in Mar. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Mar. 2024 )  (A: Mar. 2023 )(A: Mar. 2024 )
=-16.756/( (208.603+198.343 )/ 2 )
=-16.756/203.473
=-8.23 %

Decipher Labs's annualized Return-on-Tangible-Equity for the quarter that ended in Jun. 2024 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Jun. 2024 )  (Q: Mar. 2024 )(Q: Jun. 2024 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Jun. 2024 )  (Q: Mar. 2024 )(Q: Jun. 2024 )
=37.864/( (198.343+0)/ 1 )
=37.864/198.343
=19.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Jun. 2024) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Decipher Labs  (BOM:524752) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Decipher Labs Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Decipher Labs's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Decipher Labs Business Description

Traded in Other Exchanges
N/A
Address
Road No. 2, 4th Floor, Plot No. 94, Sagar Society, Banjara Hills, Hyderabad, TG, IND, 500034
Decipher Labs Ltd, formerly Combat Drugs Ltd is an India-based company engaged in the trading and manufacturing of Pharmaceutical drugs. It also undertakes contract manufacturing services business. The group generates revenue from the sale of its pharmaceutical products.

Decipher Labs Headlines

No Headlines